Pharmacy - Pharmacoeconomics News & Articles

941 Allopathic Versus Homeopathic Strategies and the Recurrence of Prescriptions: Results from a Pharmacoeconomic Study in Italy Full Text Evidence-based Complementary and Alternative Medicine , April 3, 2009

942 Cost-Effectiveness Analysis of Anticoagulation Strategies in Non-ST-Elevation Acute Coronary Syndromes Annals of Pharmacotherapy, April 1, 2009

943 The second Symptom Management Research Trial in Oncology (SMaRT Oncology-2): a randomised trial to determine the effectiveness and cost-effectiveness of adding a complex intervention for major depressive disorder to usual care for cancer patients Full Text Trials, March 31, 2009

944 SYNTAX Analysis Finds Treatment With TAXUS Express2 Stents More Cost Effective Than Bypass Surgery in Many Patients With Complex Coronary Artery Disease Full Text Boston Scientific, March 30, 2009

945 Evaluation of cost of treatment of drug-related events in a tertiary care public sector hospital in Northern India British Journal of Clinical Pharmacology, March 27, 2009

946 Topical Anesthesia Use in Children Full Text U.S. Pharmacist, March 26, 2009

947 A randomized controlled trial to evaluate short-term treatment with eosin vs. topical steroids in psoriasis Clinical and Experimental Dermatology, March 25, 2009

948 Remarks regarding a cost-effective efficiency revolution for energy and resource consumption Full Text BayNews International, March 25, 2009

949 An Elective Course in Personal Finance for Health Care Professionals Full Text American Journal of Pharmaceutical Education, March 23, 2009

950 Impact of pay for performance on quality of chronic disease management by social class group in England Journal of the Royal Society of Medicine, March 19, 2009

951 Merck Statement on New Jersey Court Ruling Denying Certification of Class of Plaintiffs Seeking Reimbursement for Out-of-Pocket VIOXX Costs Full Text Merck, March 18, 2009

952 What Is the Best Strategy for Diagnosis and Treatment of Helicobacter pylori in the Prevention of Recurrent Peptic Ulcer Bleeding? A Cost-Effectiveness Analysis Value in Health, March 17, 2009

953 Genetic Testing in Clinical Practice Annual Review of Medicine, March 16, 2009

954 The cost-effectiveness of universal screening in pregnancy for subclinical hypothyroidism American Journal of Obstetrics and Gynecology, March 13, 2009    Clinical Article

955 Challenges in Merging Medicaid and Medicare Databases to Obtain Healthcare Costs for Dual-Eligible Beneficiaries: Using Diabetes as an Example PharmacoEconomics, March 12, 2009

956 Economic evaluation of docetaxel for breast cancer Expert Opinion on Pharmacotherapy, March 11, 2009

957 Comparison of Markov Model and Discrete-Event Simulation Techniques for HIV. PharmacoEconomics, March 11, 2009

958 Neuropathic Pain: Quality-of-Life Impact, Costs and Cost Effectiveness of Therapy PharmacoEconomics, March 10, 2009

959 Economic aspects of bladder cancer: what are the benefits and costs World Journal of Urology, March 10, 2009

960 Effectiveness and Cost Effectiveness of Human Papillomavirus Vaccine PharmacoEconomics, March 9, 2009

1 Consolidated Health Economic Evaluation Reporting Standards (CHEERS) Statement Clinical Therapeutics, April 18, 2013    Review Article

2 The Economic Burden of Treatment-Resistant Depression Clinical Therapeutics, April 19, 2013

3 Application of the STOPP/START criteria: a systematic review of the prevalence of potentially inappropriate prescribing in older adults, and evidence of clinical, humanistic and economic impact Journal of Clinical Pharmacy and Therapeutics, April 10, 2013    Review Article

4 Review of Economics and Cost-Effectiveness Analyses of Anticoagulant Therapy for Stroke Prevention in Atrial Fibrillation in the US Annals of Pharmacotherapy, April 22, 2013    Review Article

5 Role of the Pharmacist in Achieving Performance Measures to Improve the Prevention and Treatment of Venous Thromboembolism Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, April 9, 2013

6 A systematic review and meta-analysis of pharmacist-led fee-for-services medication review British Journal of Clinical Pharmacology, April 24, 2013    Evidence Based Medicine    Review Article

7 Cost-Effectiveness of Dabigatran Compared With Warfarin for Stroke Prevention in Patients With Atrial Fibrillation Clinical Cardiology, March 18, 2013    Free full text

8 Cost-effectiveness of deep brain stimulation in patients with Parkinsons disease Movement Disorders, April 29, 2013

9 Cost-effectiveness of ticagrelor versus clopidogrel for the prevention of atherothrombotic events in adult patients with acute coronary syndrome in Germany Clinical Research in Cardiology, March 27, 2013

10 Is adjuvant trastuzumab a cost-effective therapy for HER-2/neu-positive T1bN0 breast cancer Annals of Oncology, March 26, 2013

11 The Cost-Effectiveness of Oral Direct Factor Xa Inhibitors Compared with Low-Molecular-Weight Heparin for the Prevention of Venous Thromboembolism Prophylaxis in Total Hip or Knee Replacement Surgery Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, April 29, 2013

12 Cost effectiveness analysis of elementary school-located vaccination against influenza-Results from a randomized controlled trial Vaccine , March 20, 2013

13 Projecting future drug expenditures in U.S. nonfederal hospitals and clinics--2013 American Journal of Health-System Pharmacy, March 13, 2013    Review Article

14 Comparable efficacy and lower cost of PBSC mobilization with intermediate-dose cyclophosphamide and G-CSF compared with plerixafor and G-CSF in patients with multiple myeloma treated with novel therapies Bone Marrow Transplantation, April 16, 2013

15 Which screening strategy should be offered to women with BRCA1 or BRCA2 mutations- A simulation of comparative cost-effectiveness British Journal of Cancer, April 15, 2013    Review Article

16 Systematic Review and Quality Assessment of Cost-Effectiveness Analysis of Pharmaceutical Therapies for Advanced Colorectal Cancer Annals of Pharmacotherapy, April 8, 2013    Evidence Based Medicine    Review Article

17 Cost analysis of adjuvant therapy with XELOX or FOLFOX4 for colon cancer Colorectal Disease, April 2, 2013

18 The long-term cost of multiple sclerosis in France and potential changes with disease-modifying interventions Multiple Sclerosis Journal, April 22, 2009

19 Economic Evaluation of Fulvestrant 500 mg Versus Generic Nonsteroidal Aromatase Inhibitors in Patients With Advanced Breast Cancer in the United Kingdom Clinical Therapeutics, March 26, 2013

20 Outcomes, Health Costs and Use of Antiplatelet Agents in 7,082 Patients Admitted for an Acute Coronary Syndrome Occurring in a Large Community Setting Cardiovascular Drugs and Therapy, March 28, 2013